Toxicological screening

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 2, 2011, Pages 74-79

  Parasuraman, S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

No Observed Adverse Effect Level; rodents; Toxicity

Indexed keywords

TOXIC SUBSTANCE;

ACUTE TOXICITY; ADVERSE OUTCOME; ARTICLE; CARCINOGEN TESTING; CARDIOTOXICITY; CHRONIC TOXICITY; DEVELOPMENTAL TOXICITY; EMBRYOTOXICITY; EVALUATION RESEARCH; EXPERIMENTAL ANIMAL; EXPERIMENTAL ANIMAL WELFARE; EXPERIMENTAL MODEL; EYE IRRITATION; GENETIC TOXICOLOGY; HISTORY OF MEDICINE; LABORATORY TEST; LD 50; LONG TERM EXPOSURE; MALIGNANT NEOPLASTIC DISEASE; MUTAGEN TESTING; NEUROTOXICITY; NONHUMAN; REPEAT PROCEDURE; REPRODUCTIVE TOXICITY; SKIN IRRITATION; SKIN SENSITIZATION; TOXICITY TESTING; TOXICOKINETICS;

EID: 84862593778     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.81895     Document Type: Article

References (34)

1. Setzer RW, Kimmel CA. Use of NOAEL, benchmark dose, and other models for human risk assessment of hormonally active substances. Pure Appl Chem 2003;75:2151-8.
2. Hunter P. A toxic brew we cannot live without. Micronutrients give insights into the interplay between geochemistry and evolutionary biology. EMBO Rep. 2008;9:15-8.
3. Gregory Cope W. Exposure classes, toxicants in air, water, soil, domestic and occupational settings. In: Hodgson E, editor. A textbook of modern toxicology. 3rd ed. Hoboken, New Jersey: John Wiley and Sons, Inc.; 2004.
4. Schedule Y. Available from: http://cdsco.nic.in/html/schedule- y%20%28amended%20version-2005%29%20original.htm. [Last accessed on 2010 Jan 02].
5. Stallard N, Whitehead A. Reducing animal numbers in the fixed-dose procedure. Hum Exp Toxicol. 1995;14:315-23.
6. ICCVAM-Recommended Test Method Protocol. The Up-and-Down Procedure for Acute Oral Systemic Toxicity. Originally published as Appendix B of "The Revised Up-and-Down Procedure: A Test Method for Determining the Acute Oral Toxicity of Chemicals", NIH Publication No. 02-4501. 2001. Available from: http://iccvam.niehs.nih.gov/methods/acutetox/udp-report.htm
7. Walum E. Acute oral toxicity. Environ Health Perspect 1998;106:497-503.
8. Guidance on dose level selection for regulatory general toxicology studies for pharmaceuticals. The Association of the British Pharmaceutical Industry (ABPI) and the British Toxicology Society (BTS) support the guidance in this document. December 2009.
9. Guidance for industry: Single dose acute toxicity testing for pharmaceuticals. Center for Drug Evaluation and Research (CDER), August 1996. Available from: http://www.fda.gov/downloads/Drugs/.../Guidances/ucm079270.pdf.
10. Diallo A, Eklu-Gadegkeku K, Agbonon A, Aklikokou K, Creppy EE, Gbeassor M. Acute and sub-chronic (28-day) oral toxicity studies of hydroalcohol leaf extract of Ageratum conyzoides L (Asteraceae). Trop J Pharmaceut Res 2010;9:463-7.
11. Acute Inhalation Toxicity, OECD (Organization for Economic Cooperation and Development) guideline for testing of chemicals. Available from: http://www.oecd.org/dataoecd/17/48/1948354.pdf.
12. York M, Steiling W. A critical review of the assessment of eye irritation potential using the Draize rabbit eye test. J Appl Toxicol 1998;18:233-40.
13. Curren RD, Harbell J W. In vitro alternatives for ocular irritation. Environ Health Perspect 1998; 106:485-92.
14. Skin Sensitization in Chemical Risk Assessment. Publications of the World Health Organization. 2008.
15. Note for Guidance on Repeated Dose Toxicity. The European agency for the evaluation of medical products, Evaluation of medicines for human use. October 2000. Available from: http://www.emea.europa.eu/. [Last accessed on 2010 Dec 25].
16. Committee for Proprietary Medical Products. Note for guidance on repeated dose toxicity. The European agency for the evaluation of medical products, Evaluation of medicines for human use. London. 2000. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003102.pdf [Last accessed on 2010 Dec 25].
17. OECD Template #67: Repeated dose toxicity: Oral. Available from: http://www.oecd.org/dataoecd/56/40/45616929.html. [Last accessed on 2010 Dec 24].
18. Eastmond DA, Hartwig A, Anderson D, Anwarb WA, Cimino MC, Dobrev I, et al. Mutagenicity testing for chemical risk assessment: Update of the WHO/IPCS Harmonized Scheme. Mutagenesis 2009;24:341-9.
19. Gholami S, Soleimani F, Shirazi FH, Touhidpour M, Mahmoudian M. Evaluation of mutagenicity of mebudipine, a new calcium channel blocker. Iran J Pharmaceut Res 2010;9:49-53.
20. Sub-chronic oral toxicity test, repeated dose 90 - day oral toxicity study in non-rodents. Accessed from: http://www.intermed.it/istbiotech/reach/ B27web2001.pdf. [Last accessed on 2010 Dec 20].
21. Muralidhara S, Ramanathan R, Mehta SM, Lash LH, Acosta D, Bruckner J V. Acute, subacute, and subchronic oral toxicity studies of 1,1-dichloroethane in rats: Application to risk evaluation. Toxicol Sci 2001;64:135-45.
22. Jaijoy K, Soonthornchareonnon N, Lertprasertsuke N, Panthong A, Sireeratawong S. Acute and chronic oral toxicity of standardized water extract from the fruit of Phyllanthus emblica Linn. Int. J Appl Res Natl Prod 2010;3:48-58.
23. Carcinogenicity Test. Available from: http://ecb.jrc.ec.europa.eu/ documents/Testing-Methods/ANNEXV/B32web1988.pdf. [Last accessed on 2011 Jan 02].
24. OECD Guideline for the Testing of Chemicals. Available from: http://www.oecd.org/dataoecd/20/52/37622194.pdf. [Last accessed on 2011 Jan 05].
25. Matsuura I, Saito T, Tani E, Wako Y, Iwata H, Toyota N, et al. Evaluation of a two-generation reproduction toxicity study adding endopoints to detect endocrine disrupting activity using lindane. J Toxicol Sci 2005;30:135-61.
26. Ganiger S, Malleshappa HN, Krishnappa H, Rajashekhar G, Ramakrishna Rao V, Sullivan F. A two generation reproductive toxicity study with curcumin, turmeric yellow, in Wistar rats. Food Chem Toxicol 2007;45:64-9.
27. Zepnik H, Volkel W, Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol Appl Pharmacol 2003;192:36-44.
28. Payan J P, Boudry I, Beydon D, Fabry J P, Grandclaude MC, Ferrari E, et al. Toxicokinetics and metabolism of N-[14C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: In vivo and in vitro percutaneous absorption. Drug Metabol Dispos 2003;31:659-69.
29. Kimm-Brinson K, Ramsdell JS. The red tide toxin, brevetoxin, induces embryo toxicity and developmental abnormalities. Environ. Health Perspectives 2001;109:377-81.
30. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol 2002;21:181-9.
31. Booth A, Amen RJ, Scott M, Greenway FL. Oral dose-ranging developmental toxicity study of an herbal supplement (NT) and gallic acid in rats. Adv Ther 2010;27:250-5.
32. Oliveira CD, Moreira SQ, Marques de Sá LR, Spinosa Hde, Yonamine M. Maternal and developmental toxicity of ayahuasca in Wistar rats. Birth Defects Res B Dev Reprod Toxicol 2010;89:207-12.
33. Reproductive and Developmental Toxicity. Available from: http://alttox.org/ (non-animal methods of toxicity testing). [Last accessed on 2010 Dec 24].
34. Robinson S, Chapman K, Hudson S, Sparrow S, Spencer-Briggs D, Danks A, et al. Guidance on dose level selection for regulatory general toxicology studies for pharmaceuticals. London. 2009. National Centre for the Replacement, Refinement and Reduction of Animals in Research Laboratory Animal Science Association (NC3Rs)/Laboratory Animal Science Association (LASA). Available from: http://www.nc3rs.org.uk/document.asp?id=1317 [last accedes on 2010 Dec 25]